United States Holding Companies

Vincerx Pharma Inc (VINC)

Track

Track

Ticker: VINC Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Vincerx Pharma Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Seelenberger Alexander A. See Remarks Officer
Transaction date
Planned purchase
Price
370.62
Quantity 46,066 -10.1%
Value US$1,355,724
2.6
Hamdy Ahmed MD See Remarks Executive Director
Transaction date
Purchase
Price
297.55
Quantity 39,723 +33.4%
Value US$1,405,528
2.5
THOMAS TOM C See Remarks Officer
Transaction date
Planned purchase
Price
125.43
Quantity 36,408 +11.8%
Value US$2,397,945
2.7
Izumi Raquel E. See Remarks Executive Director
Transaction date
Purchase
Price
0.93
Quantity 3,440 +4.2%
Value US$3,199
2.6
Hamdy Ahmed MD See Remarks Executive Director
Transaction date
Purchase
Price
0.95
Quantity 16,900 +22.9%
Value US$15,994
2.7
Izumi Raquel E. See Remarks Executive Director
Transaction date
Purchase
Price
0.90
Quantity 13,036 +19.0%
Value US$11,735
2.5
THOMAS TOM C See Remarks Officer
Transaction date
Purchase
Price
0.83
Quantity 7,000 +233.3%
Value US$5,810
2.6
Hamdy Ahmed MD Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.87
Quantity 35,280 +91.7%
Value US$30,538
2.7
Izumi Raquel E. See Remarks Executive Director
Transaction date
Purchase
Price
0.88
Quantity 28,738 +71.8%
Value US$25,427
0.8
LOWE CHRISTOPHER P. Non-Executive Director
Transaction date
Purchase
Price
1.65
Quantity 11,600 +40.8%
Value US$19,139
0.8
LOWE CHRISTOPHER P. Non-Executive Director
Transaction date
Purchase
Price
1.65
Quantity 18,400 +184.0%
Value US$30,299
2.7
Izumi Raquel E. See Remarks Executive Director
Transaction date
Purchase
Price
1.41
Quantity 40,000 +inf%
Value US$56,312
2.6
Hamdy Ahmed MD Chief Executive Officer Executive Director
Transaction date
Purchase
Price
1.41
Quantity 24,200 +169.5%
Value US$34,137
0.6
Bushnell Laura I. Non-Executive Director
Transaction date
Purchase
Price
1.91
Quantity 15,000 +357.0%
Value US$28,624
2.7
Izumi Raquel E. See Remarks Executive Director
Transaction date
Purchase
Price
11.96
Quantity 1,000 +inf%
Value US$11,960
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-08-14 2023-08-11 PP Planned purchase
Seelenberger Alexander A.

See Remarks

Officer
46,066 -10.1%
370.62
US$1,355,724 		46,066 -10.1% 370.62 US$1,355,724
2023-08-10 2023-08-10 B Purchase
2.6
Hamdy Ahmed MD

See Remarks

Executive Director
39,723 +33.4%
297.55
US$1,405,528 		39,723 +33.4% 297.55 US$1,405,528
2023-08-10 2023-08-10 PP Planned purchase
2.5
THOMAS TOM C

See Remarks

Officer
36,408 +11.8%
125.43
US$2,397,945 		36,408 +11.8% 125.43 US$2,397,945
2023-08-10 2023-08-10 B Purchase
2.7
Izumi Raquel E.

See Remarks

Executive Director
3,440 +4.2%
0.93
US$3,199 		3,440 +4.2% 0.93 US$3,199
2023-08-10 2023-08-09 B Purchase
2.6
Hamdy Ahmed MD

See Remarks

Executive Director
16,900 +22.9%
0.95
US$15,994 		16,900 +22.9% 0.95 US$15,994
2023-08-10 2023-08-09 B Purchase
2.7
Izumi Raquel E.

See Remarks

Executive Director
13,036 +19.0%
0.90
US$11,735 		13,036 +19.0% 0.90 US$11,735
2022-12-14 2022-12-14 B Purchase
2.5
THOMAS TOM C

See Remarks

Officer
7,000 +233.3%
0.83
US$5,810 		7,000 +233.3% 0.83 US$5,810
2022-12-14 2022-12-14 B Purchase
2.6
Hamdy Ahmed MD

Chief Executive Officer

Executive Director
35,280 +91.7%
0.87
US$30,538 		35,280 +91.7% 0.87 US$30,538
2022-12-14 2022-12-14 B Purchase
2.7
Izumi Raquel E.

See Remarks

Executive Director
28,738 +71.8%
0.88
US$25,427 		28,738 +71.8% 0.88 US$25,427
2022-08-26 2022-08-25 B Purchase
0.8
LOWE CHRISTOPHER P.
Non-Executive Director
11,600 +40.8%
1.65
US$19,139 		11,600 +40.8% 1.65 US$19,139
2022-08-26 2022-08-24 B Purchase
0.8
LOWE CHRISTOPHER P.
Non-Executive Director
18,400 +184.0%
1.65
US$30,299 		18,400 +184.0% 1.65 US$30,299
2022-06-29 2022-06-27 B Purchase
2.7
Izumi Raquel E.

See Remarks

Executive Director
40,000 +inf%
1.41
US$56,312 		40,000 +inf% 1.41 US$56,312
2022-06-27 2022-06-23 B Purchase
2.6
Hamdy Ahmed MD

Chief Executive Officer

Executive Director
24,200 +169.5%
1.41
US$34,137 		24,200 +169.5% 1.41 US$34,137
2022-06-13 2022-06-09 B Purchase
0.6
Bushnell Laura I.
Non-Executive Director
15,000 +357.0%
1.91
US$28,624 		15,000 +357.0% 1.91 US$28,624
2021-08-06 2021-08-04 B Purchase
2.7
Izumi Raquel E.

See Remarks

Executive Director
1,000 +inf%
11.96
US$11,960 		1,000 +inf% 11.96 US$11,960
Explore more

More insider trading research around Vincerx Pharma Inc

More insider trades in United States
Similar Financials companies with insider activity
More Holding Companies companies with insider activity
More Holding Companies companies with insider activity
Insider trading in North America